ZOLL Receives Clearance To Market R Series Code-Ready Defibrillator With WiFi Option

ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the ZOLL R Series® Code-Ready® clinical defibrillator with a WiFi option that allows wireless communication between the defibrillator and standard hospital networks to help ensure code-readiness and download patient data. Based on standard 802.

More: continued here

Filed under: IT / Internet / E-mail on January 3rd, 2009